From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease managementElías Mossialos, Ingrid Sketris, Émilie Courtin et al.|Health Policy|2015Cited by 456
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysisHuseyin Naci, Christopher M. Booth, Courtney Davis et al.|BMJ|2019Cited by 242
Generating comparative evidence on new drugs and devices before approvalHuseyin Naci, Andrea Cipriani, Maximilian Salcher‐Konrad et al.|The Lancet|2020Cited by 80
Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysisAntonios Athanasiou, Maria Kyrgiou, Areti Angeliki Veroniki et al.|The Lancet Oncology|2022Cited by 76
Planning a future randomized clinical trial based on a network of relevant past trialsGeorgia Salanti, Matthias Egger, Adriani Nikolakopoulou et al.|Trials|2018Cited by 53